
DocMorris AG
SIX:DOCM

Intrinsic Value
The intrinsic value of one
DOCM
stock under the Base Case scenario is
16.05
CHF.
Compared to the current market price of 6.3 CHF,
DocMorris AG
is
Undervalued by 61%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
DocMorris AG
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
DocMorris AG
Balance Sheet Decomposition
DocMorris AG
Current Assets | 202.9m |
Cash & Short-Term Investments | 67.1m |
Receivables | 66m |
Other Current Assets | 69.9m |
Non-Current Assets | 566.6m |
Long-Term Investments | 13.6m |
PP&E | 49.1m |
Intangibles | 498.2m |
Other Non-Current Assets | 5.8m |
Free Cash Flow Analysis
DocMorris AG
CHF | |
Free Cash Flow | CHF |
Earnings Waterfall
DocMorris AG
Revenue
|
1.3B
CHF
|
Cost of Revenue
|
-1B
CHF
|
Gross Profit
|
278.1m
CHF
|
Operating Expenses
|
-395.8m
CHF
|
Operating Income
|
-117.7m
CHF
|
Other Expenses
|
-4.8m
CHF
|
Net Income
|
-122.5m
CHF
|
DOCM Profitability Score
Profitability Due Diligence
DocMorris AG's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Score
DocMorris AG's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
DOCM Solvency Score
Solvency Due Diligence
DocMorris AG's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Score
DocMorris AG's solvency score is 35/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DOCM Price Targets Summary
DocMorris AG
According to Wall Street analysts, the average 1-year price target for
DOCM
is 12.75 CHF
with a low forecast of 8.08 CHF and a high forecast of 20.68 CHF.
Dividends
Current shareholder yield for DOCM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
DOCM
stock under the Base Case scenario is
16.05
CHF.
Compared to the current market price of 6.3 CHF,
DocMorris AG
is
Undervalued by 61%.